Clinical research coordinator screening questions: CCRC and CCRP, GCP under ICH E6(R3), consent, safety reporting and source documents
On this page
- Which clinical research coordinator job is it?
- Which certifications, training and rules apply?
- Knockout questions
- Consent, eligibility and safety questions
- Source documents, monitoring and specimen questions
- How does clinical research coordinator experience get overstated?
- A 15-minute phone-screen flow
- Scoring
- What to put in the submittal
- Lawful phrasing
- Questions people ask
Clinical research coordinator screening questions should establish which kinds of studies the candidate has coordinated (drug, device or behavioral; industry-sponsored or investigator-initiated; which phases and therapeutic areas), what they did themselves (prescreening and recruitment, informed consent, eligibility checks, study visits, adverse event documentation, source documents, data entry, monitoring visits and the regulatory binder), and whether they know the rules behind those tasks: Good Clinical Practice under ICH E6(R3), FDA's consent and recordkeeping regulations, and the protocol's safety reporting timelines. As of November 2026, the two certifications most sites recognize are ACRP's CCRC and SOCRA's CCRP; neither is legally required, and both need verifiable coordinator experience before a candidate can sit for them.
The interview guide for research roles lays out a full loop for research associates, scientists and study coordinators; this page is the screen that comes first, and the 30-60-90 day plan for clinical research coordinators covers what comes after the hire. If the role is heavy on specimens, add questions from the phlebotomist screening questions or the medical lab scientist screening questions; for research nurse coordinators, add the registered nurse screening questions and check the license.
Which clinical research coordinator job is it?
| Seat | What the coordinator mostly does | Ask the candidate |
|---|---|---|
| Industry-sponsored drug trials at a site | Prescreening, consent, study visits, data entry in the sponsor's system, monitoring visits | "Which phases and therapeutic areas, and how many active studies did you carry at once?" |
| Device studies | Studies under an investigational device exemption, device accountability, procedure scheduling | "Did you handle device accountability and returns yourself?" |
| Investigator-initiated or academic studies | IRB submissions, the regulatory binder, sometimes the study database and registration support | "Who wrote the IRB submissions and amendments?" |
| Oncology | Complex protocols, strict visit and imaging windows, many amendments | "How did you track windows across a long treatment schedule?" |
| Regulatory coordinator | Essential documents, IRB correspondence, sponsor start-up packets, training records | "How many studies' regulatory files did you keep, and in what system?" |
| Research nurse coordinator | Clinical assessments and study drug administration under a nursing license | Check the license and use the nurse questions as well. |
Ask the site for the study types and phases, the number of active studies per coordinator, whether the role draws blood or processes and ships specimens, evening or weekend visits, travel between sites, and which systems they use for data capture, trial management and regulatory files.
Which certifications, training and rules apply?
As of November 2026. We checked these on ACRP's, SOCRA's, NIH's, FDA's, OIG's and the California Department of Public Health's sites and in the FDA regulations. Sponsors, IRBs and institutions add their own requirements; check the site's.
- CCRC (ACRP). ACRP's CCRC page asks for 3,000 hours of verifiable clinical research work experience, excluding internships, work done as part of a degree program and experience older than ten years, with a possible 1,500-hour waiver for an active ACRP certification or an approved education program. The exam has 125 multiple-choice questions in 180 minutes, tests ICH guidelines rather than country-specific rules, and moved from ICH E6(R2) to E6(R3) from July 15, 2026. Certification is maintained every two years.
- CCRP (SOCRA). SOCRA's CCRP page lists three routes: two years of full-time clinical research work (or 3,500 part-time hours) within the last five years; a clinical research degree plus one year (or 1,750 part-time hours) within the last two; or a clinical research certificate plus a science or health degree plus one year within the last two.
- GCP. ICH's E6(R3) guideline reached its final step on January 6, 2025, and FDA issued E6(R3) Good Clinical Practice as final guidance in September 2025, describing flexible, risk-based approaches. For NIH-funded trials, NOT-OD-16-148 requires GCP training for investigators and staff involved in conducting, overseeing or managing the trial, refreshed at least every three years.
- Consent and records. 21 CFR 50.27(a) requires consent documented on an IRB-approved written form, signed and dated by the participant or legally authorized representative at the time of consent, with a copy given. For drug studies, 21 CFR 312.62 requires adequate and accurate case histories, including signed and dated consent forms and medical records, showing consent was obtained before participation, kept for two years after approval of the marketing application or after the investigation ends and FDA is notified.
- Safety reporting. 21 CFR 312.64(b) requires an investigator to report any serious adverse event to the sponsor immediately, whether or not it is considered drug related; endpoints that are serious adverse events follow the protocol unless there is evidence of a causal relationship.
- Exclusion and debarment checks. FDA's Debarment List is a public list of firms and persons currently debarred under the FD&C Act, and OIG says health care entities should routinely check new hires against its exclusion list.
- Blood draws are state-regulated. If the coordinator draws blood, check the state's rules; California's Department of Public Health, for example, issues three levels of phlebotomy certification, each with a different scope.
Knockout questions
| Question | Strong answer | Red flag |
|---|---|---|
| 1. How many studies have you coordinated in the last two years, of which types and phases, and how many at once? | Counts by type and phase: "Six industry drug studies, phases 2 and 3, four active at a time, plus one device study." | The site's whole study list offered as their own. |
| 2. Which therapeutic areas, and which of those studies did you consent participants for? | Named areas and their role in consent for each. | Has never consented anyone, for a coordinator role that requires it. |
| 3. When did you last complete GCP training, and do you hold the CCRC or CCRP? | A date and provider, and a credential with an issuing body you can verify, or an honest no. | "Certified" with no credential name. |
| 4. The role includes [blood draws, specimen processing and shipping, evening visits, travel between sites]. Can you do that? | Yes, with experience, or a clear limit. | Unaware the role is hands-on. |
| 5. Are you legally authorized to work in the US, and will you now or in the future need visa sponsorship? | A direct answer to both, asked the same way of everyone. | None from the answer itself. |
Consent, eligibility and safety questions
-
"Walk me through an informed consent visit you conducted."
- Strong answer: the current IRB-approved version, a private setting, time to read and ask questions, a check of understanding, signature and date at the time of consent, a copy given, a note documenting the process, and no study procedures before consent; only staff on the delegation log obtain consent.
- Red flags: procedures started before the signature, an outdated version, or "I just get the form signed."
-
"The protocol was amended mid-study. What happened to participants already enrolled?"
- Strong answer: waited for IRB approval before implementing, re-consented with the new version where required, retrained staff and updated the files.
- Red flags: started the new procedures before approval.
-
"How do you confirm a participant meets the eligibility criteria?"
- Strong answer: a checklist against every inclusion and exclusion criterion with source documents, lab and visit windows checked, and investigator sign-off before enrollment or randomization.
- Red flags: works from memory, or enrolls borderline participants and "sorts it out later."
-
"A participant mentions an emergency room visit last week. What do you do?"
- Strong answer: gets the records, has the investigator assess seriousness and relatedness, reports a serious adverse event to the sponsor immediately under the protocol's process, documents it, and follows the IRB's reporting policy.
- Red flags: waits for the next visit, or decides relatedness without the investigator.
-
"Tell me about a protocol deviation you reported. What changed afterward?"
- Strong answer: a missed window or procedure, reported as the sponsor and IRB require, with a corrective and preventive step that stopped it recurring.
- Red flags: never had one, or kept it out of the file.
Source documents, monitoring and specimen questions
| Question | Strong answer | Red flag |
|---|---|---|
| How do you correct an error in a paper source document? | A single line through it, the correction, initials, date and reason; original entry still readable. In electronic systems, the audit trail does the same. | Correction fluid, or rewriting the page. |
| How quickly did you enter visit data, and how did you handle queries? | Within the sponsor's timeline, queries answered from source, a weekly check of open queries. | A standing backlog of weeks. |
| What did you prepare before a monitoring visit? | Source available, regulatory binder current, investigational product accountability reconciled, open queries listed. | "The monitor finds what they find." |
| How did you handle investigational product accountability? | Dispensing and return logs, temperature records, reconciliation with the pharmacy. | No idea who tracked it. |
| Have you processed and shipped specimens? | Followed the lab manual for processing, labeling and packaging, with the shipping training the sponsor or courier required. | Never shipped, for a specimen-heavy role. |
| Have you been through a sponsor audit or FDA inspection? | What was reviewed, their part, any findings and the response. | Not sure whether it happened. |
How does clinical research coordinator experience get overstated?
- Scheduling as coordinating. Booked visits for studies others ran. Ask which tasks they did at the visit.
- Witnessing as consenting. Ask how many participants they consented themselves, and on which studies.
- The site's study count. "Thirty studies" from the roster. Ask how many they carried.
- Training as experience. A GCP certificate with no study work. Useful, but not coordination.
- "Certification eligible" offered as certified. Verify with ACRP or SOCRA.
- Data entry as data management. Ask who designed the forms and resolved queries.
A 15-minute phone-screen flow
- Minutes 0 to 2: study types and phases, active studies per coordinator, hands-on tasks, schedule.
- Minutes 2 to 5: knockouts 1 to 5; note credentials and GCP dates to verify.
- Minutes 5 to 10: the consent visit and the emergency room question. Write down steps and timelines in their words.
- Minutes 10 to 13: eligibility or the amendment question, and one source or monitoring question.
- Minutes 13 to 15: pay expectations (see salary expectation questions) and next steps.
Scoring
Pass or fail
- Recent coordinator work on the study types the site runs.
- Has consented participants, if the role requires it.
- Current GCP training, and any credential the site requires, verified.
- Can do the hands-on tasks, schedule and travel, with or without accommodation.
Scored 0 to 2 each (10 possible)
- Consent process and re-consent.
- Eligibility and protocol adherence.
- Safety reporting and deviations.
- Source documents, data entry and query handling.
- Monitoring, product accountability and specimens.
What to put in the submittal
Clinical research coordinator: [name]
Studies, last 2 years: [count], [drug / device / behavioral], phases [ ], therapeutic areas [ ]
Active studies at once: [number]
Consent: [participants consented, studies], re-consent experience [yes or no]
Safety reporting: [summary of the ER-visit answer]
Systems: [data capture], [trial management], [regulatory files]
Hands-on: [blood draws, processing, shipping], state certificate if required [ ]
Credentials: [CCRC / CCRP / none], verified [date]; GCP training [date, provider]
Monitoring and audits: [summary]
Candidate's own gap: [e.g. "no device studies; has not consented participants with a legal representative"]
Lawful phrasing
Describe the job's tasks (standing during visits, lifting specimen boxes, handling dry ice, evening visits) and ask whether the candidate can perform them with or without accommodation; leave medical questions and any health clearance until after a conditional offer, as described in pre-employment medical exams and the ADA. Ask candidates to describe study work without naming participants, sponsors' confidential protocols or anything covered by their confidentiality agreements; see does HIPAA apply to job interviews. Credential checks are covered in how to verify candidate certifications. This page is not legal advice.
Questions people ask
What certification should a clinical research coordinator have?
The two most recognized are ACRP's Certified Clinical Research Coordinator (CCRC) and SOCRA's Certified Clinical Research Professional (CCRP). As of November 2026, the CCRC needs 3,000 hours of verifiable clinical research work experience and is maintained every two years, and SOCRA's main route needs two years of full-time clinical research work within the last five. Neither is legally required; many sites hire experienced coordinators without one.
What is ICH E6(R3)?
It is the current revision of the International Council for Harmonisation's Good Clinical Practice guideline, built around risk-based, quality-by-design trial conduct. ICH adopted its principles and Annex 1 in January 2025, and the FDA issued E6(R3) as final guidance in September 2025. ACRP's certification exams switched from E6(R2) to E6(R3) from July 15, 2026, so a recently certified coordinator should know the revision.
How often do clinical research staff need GCP training?
For NIH-funded clinical trials, NIH policy NOT-OD-16-148 requires investigators and staff involved in conducting, overseeing or managing the trial to complete Good Clinical Practice training and refresh it at least every three years. Sponsors and institutions often set their own requirements as well, so check the site's policy.
How quickly must a study site report a serious adverse event?
For drug studies under an IND, 21 CFR 312.64(b) says an investigator must immediately report to the sponsor any serious adverse event, whether or not it is considered drug related; study endpoints that are serious adverse events follow the protocol unless there is evidence of a causal relationship. The protocol and the IRB's policy set the exact timelines and forms, and a coordinator should know both.